Navigation Links
Unilife Corporation Announces Pricing of Offering of 8,250,000 Shares of Common Stock
Date:11/16/2011

YORK, Pa., Nov. 16, 2011 /PRNewswire/ -- Unilife Corporation (NASDAQ: UNIS / ASX: UNS) ("Unilife" or the "Company") today announced the pricing of its underwritten registered public offering of 8,250,000 shares of common stock at a public offering price of $4.35 per share. All of the shares in the offering are to be sold by Unilife. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,237,500 shares of common stock to cover over-allotments, if any.

The net proceeds of the offering to the Company, after deducting the underwriting discount and estimated offering expenses, are expected to be approximately $33,808,125, exclusive of any proceeds attributable to the underwriters' possible exercise of their over-allotment option. Unilife expects to use the net proceeds from this offering to fund the continued development and commercial supply of its diversified portfolio of advanced drug delivery systems, the expansion of its workforce to support anticipated customer demands, and for working capital and other general corporate purposes. The offering is expected to close on November 21, 2011 and is subject to customary closing conditions.

Jefferies & Company, Inc. is acting as sole book-running manager for the offering.  Leerink Swann LLC is acting as co-lead manager for the offering and Griffin Securities, Inc. is acting as co-manager for the offering.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Unilife, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.  This press release is being issued pursuant to and in accordance with Rule 134 of the Securities Act of 1933, as amended.

A shelf registration statement relating to the shares was filed with the Securities and Exchange Commission and is effective. A preliminary prospectus supplement related to the offering has been filed with the Securities and Exchange Commission (SEC) and a final prospectus supplement will be filed with the SEC and will be available on the SEC's website located at www.sec.gov. When available, copies of the final prospectus supplement relating to this offering may be obtained from Equity Syndicate Prospectus Department, Jefferies & Company, Inc., 520 Madison Avenue, 12th Floor, New York, NY, 10022, at 877-547-6340, and at Prospectus_Department@Jefferies.com.

About Unilife Corporation Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of a diversified portfolio of advanced drug delivery systems.  Unilife collaborates with pharmaceutical and biotechnology companies seeking to optimize drug lifecycles and generate differentiation for their brand in competitive therapeutic markets through the use of innovative devices that can improve patient care, protect healthcare workers and prevent disease. Unilife has developed a broad portfolio of drug delivery systems in direct response to unmet market needs for macromolecule injectable drugs including biologics.  

Safe Harbor Statement This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K, in the final prospectus supplement and related prospectus relating to the offering and those described from time to time in other reports which we file with the Securities and Exchange Commission.  

General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

Stuart Fine

Jeff CarterKCSA Strategic Communications

Carpe DM Inc

Unilife CorporationP: + 1 212-682-6300

P: + 1 908 469 1788

P: + 61 2 8346 6500
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Corporation Announces Proposed Public Offering of Common Stock
2. Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter
3. Unilife Corporation to Announce Financial Results For Fiscal 2012 First Quarter on Wednesday, November 9, 2011
4. Unilife Announces Internet Availability of Proxy Materials for its 2011 Annual Meeting of Stockholders
5. Unilife Wins Supply Contract with Nations Largest Healthcare Alliance
6. Unilife CEO to Purchase an Additional U.S. $500,000 in Company Shares by September 30, 2011
7. Unilife to Present at the Jefferies 2011 Global Healthcare Conference in London
8. Unilife to Present at the 2011 UBS Global Life Sciences Conference in New York City
9. Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients
10. Unilife to Participate in Two Investor Conferences
11. Unilife COO to Again Purchase More Than $250,000 in Company Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... DUBLIN , Mar 01, 2017 Research and ... of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases" report to ... Did you ... Sales & Marketing, U.S. Breast/Colon at Genomic Health, Inc.. - Beijing ... manufacturing base for the production of infectious diseases diagnostics in ...
(Date:3/1/2017)... , March 1, 2017  The Welch Foundation, one ... basic research, today announced that Drs. Neal M. ... the 2017 recipients of the Norman Hackerman ... as ,rising stars, having contributed significant scientific discoveries at ... time in the 15 years of the Hackerman Award ...
(Date:3/1/2017)... -- The global  Intraoperative Neuromonitoring (IONM) market  is expected to reach ... Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in ... in a wide spectrum of surgeries. Continue Reading ... ... ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... Today, True Vision Funding LLC ... formation of a new division for the purchase of sports and music entertainment ... , Clinton Portis, former Washington Redskins running back and supporter for TVF ...
(Date:3/1/2017)... ... March 01, 2017 , ... Financial Recovery Group, Inc. (FRG), is ... Nashville Summit in Nashville, Tenn. The company also is offering a special discount for ... in its 11th year, brings together the brightest minds in the healthcare industry to ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... pleased to announce the release of its 2017 update to Compass, the ... staff and physician advisors. , Suitable for standardizing both new-hire on-boarding and ...
(Date:3/1/2017)... ANGELES, CA (PRWEB) , ... March 01, 2017 , ... ... launch of her new mobile app Time & Go. , Time & Go app ... of life: career, relationships, and well-being. Efficient time management methods enable people to work ...
(Date:3/1/2017)... ... March 01, 2017 , ... “There is Comfort for the Soul”: ... the author in their all-too-brief time together, and the soul-healing comfort provided by God’s ... the creation of published author, Jerie A. Tau, a dog-loving medical professional whose work ...
Breaking Medicine News(10 mins):